Huons Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Huons Stock Forecast and Price Target
The average target price set lately by experts for Huons to reach by the end of the year is ₩54000.00, which would imply a potential upside of approximately 56.52 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of ₩54000.00 and a low estimate of ₩54000.00. If you're interested in A243070 stock, it's important to compare it to other companies in the industry.
56.52% Upside
Huons Fair Value Forecast for 2023 - 2025 - 2030
Huons's Price has decreased In the last four years, from ₩67.19k to ₩0.00 – a 100.00% drop. For the next year, analysts predict that Fair Value will reach ₩0.00 – an increase of 100.00%. Over the next six years, experts believe that Huons's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A128940 Stock Forecast | Hanmi Pharm. | Outperform |
18
|
₩316.50k | Buy/Sell | ₩382.71k | 31.12% |
| A008930 Stock Forecast | Hanmi Science | - |
14
|
₩42.55k | Buy/Sell | ₩0.00 | -100.00% |
| A000250 Stock Forecast | Sam Chun Dang Pharm. | - |
6
|
₩104.60k | Buy/Sell | ₩80.00k | -100.00% |
| A145020 Stock Forecast | Hugel | Buy |
16
|
₩211.50k | Buy/Sell | ₩201.75k | 3.55% |
| A009420 Stock Forecast | Hanall Biopharma | Buy |
14
|
₩36.10k | Buy/Sell | ₩44.67k | 24.65% |
Huons Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Huons's Revenue has grown by 21.08%, rising from ₩406.68B to ₩492.39B. In the following year, 0 experts forecast Huons's Revenue will decrease by 9.82%, to ₩444.03B. In 2030, professionals predict that Huons's Revenue will decrease by 9.33%, to ₩446.43B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A019170 Stock Forecast | Shinpoong Pharmaceutical Co.,L... | - |
14
|
₩12.96k | Buy/Sell | ₩0.00 | -100.00% |
| A185750 Stock Forecast | Chong Kun Dang Pharmaceutical | Outperform |
16
|
₩104.30k | Buy/Sell | ₩124.29k | 43.82% |
| A069620 Stock Forecast | Daewoong pharmaceutical Co.,Lt... | Buy |
16
|
₩111.90k | Buy/Sell | ₩156.10k | 38.52% |
.jpg)
Huons Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Huons's Dividend per Share has grown, moving from ₩495.87 to ₩600.00 – an increase of 21.00%. According to 0 major analysts, Huons's Dividend per Share will fall by 9.09% in the next year, reaching ₩545.46. Professionals believe that By 2030, Huons's Dividend per Share will fall to ₩548.11– a 8.65% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A005250 Stock Forecast | Green Cross Holdings | - |
16
|
₩16.17k | Buy/Sell | ₩0.00 | -100.00% |
| A003090 Stock Forecast | Daewoong | Outperform |
14
|
₩18.82k | Buy/Sell | ₩38.00k | 32.84% |
| A003850 Stock Forecast | Boryung | Buy |
17
|
₩11.15k | Buy/Sell | ₩13.50k | 43.50% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A086450 Stock Forecast | DongKook Pharmaceutical | Buy |
16
|
₩16.48k | Buy/Sell | ₩20.00k | 45.63% |
| A001060 Stock Forecast | JW Pharmaceutical | Buy |
14
|
₩30.95k | Buy/Sell | ₩40.62k | 35.70% |
| A000640 Stock Forecast | Dong-A Socio Holdings | - |
13
|
₩110.20k | Buy/Sell | ₩0.00 | -100.00% |
Huons EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Huons's EBITDA has fallen from ₩65.95B to ₩57.60B – a 12.67% decrease. In the next year, analysts believe that EBITDA will reach ₩60.54B – an increase of 5.10%. For the next eight years, the forecast is forEBITDA to grow by 5.17%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A170900 Stock Forecast | Dong-A ST | Outperform |
17
|
₩67.60k | Buy/Sell | ₩74.50k | 20.56% |
| A058820 Stock Forecast | CMG Pharmaceutical | - |
14
|
₩2.24k | Buy/Sell | ₩0.00 | -100.00% |
| A140410 Stock Forecast | Mezzion Pharma | - |
6
|
₩36.55k | Buy/Sell | ₩0.00 | -100.00% |
Huons EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Huons's EBIT has decreased from ₩54.12B to ₩40.87B – a 24.50% drop. In the coming year, analysts are expecting an increase in EBIT, predicting it will reach ₩46.47B – an increase of 13.71%. Over the next eight years, experts anticipate that EBIT growth for Huons will be 14.66%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A102460 Stock Forecast | REYON Pharmaceutical | - |
15
|
₩15.75k | Buy/Sell | ₩0.00 | -100.00% |
| A047920 Stock Forecast | HLB Pharmaceutical | - |
4
|
₩34.10k | Buy/Sell | ₩0.00 | -100.00% |
| A003000 Stock Forecast | Bukwang Pharmaceutical | - |
10
|
₩6.36k | Buy/Sell | ₩17.66k | -100.00% |
Huons EPS Price Prediction Forecast for 2023 - 2025 - 2030
Huons's EPS has decreased In the last four years, from ₩5101.82 to ₩0.00 – a 100.00% drop. For the next year, analysts predict that EPS will reach ₩0.00 – an increase of 100.00%. Over the next six years, experts believe that Huons's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A249420 Stock Forecast | Ildong Pharmaceutical | Outperform |
12
|
₩15.53k | Buy/Sell | ₩23.00k | 60.98% |
| A053030 Stock Forecast | BINEX | - |
16
|
₩14.01k | Buy/Sell | ₩18.00k | -100.00% |
| A007570 Stock Forecast | Ilyang Pharmaceutical Co.,Ltd | - |
13
|
₩14.56k | Buy/Sell | ₩0.00 | -100.00% |
.jpg)